Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Binimetinib
Carcinoma Of Esophagus
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Gastric Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Head And Neck Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Hematopoietic And Lymphoid Cell Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Renal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Hepatocellular Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Female Reproductive Organ Cancer
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Uterine Corpus Cancer
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Uterine Cancer
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Her2-Receptor Negative Breast Cancer
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Hormone Receptor-Positive Breast Cancer
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Ovarian Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Prostate Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Fallopian Tube Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Thyroid Gland Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Ovarian Cancer
National Cancer Institute (NCI)P2CCC (53)
Bn-Brachyury
Castration-Resistant Prostate Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Botensilimab
Renal Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
ca-4948
Acute Myeloid Leukemia With Multilineage Dysplasia
National Cancer Institute (NCI)P2CCC (53)
ca-4948
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
National Cancer Institute (NCI)P2CCC (53)
Cabozantinib
Adrenal Cortex Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Cabozantinib
Alveolar Soft Part Sarcoma
National Cancer Institute (NCI)P2CCC (53)
Cabozantinib
Anal Melanoma
National Cancer Institute (NCI)P2CCC (53)
Cabozantinib
Bladder Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Showing 1076 to 1100 of 3,272 assets
PreviousPage 44 of 131Next